Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established.

Respiratory virus infections among hospitalized patients with suspected influenza A H1N1 2009 virus during the first pandemic wave in Brazil.. Schnepf N, Resche-Rigon M, Chaillon

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus

Noninvasive imaging can provide real-time in vivo monitoring of the progression of infection, inflammation and disease that may give insight into the mechanisms that modulate

GMTs for the various influenza HA1 antigens in subjects vaccinated with inactivated MF-59 adjuvated pandemic Influenza A virus (H1N1) 2009, with and without a history of

The 1918 wild- type virus and a virus possessing the 1918 viral RNA polymerase complex genes (i.e., PA, PB1, PB2, and NP) replicated efficiently in both the upper and lower

The hemagglutinin and the neuraminidase that project from the surface of the influenza A virus undergo frequent antigenic changes. The minor changes, which occur

In view of the pandemic caused by a new virus, influenza A (H1N1), we report the case of a 56-year-old patient without relevant risk factors and with severe acute respiratory

Ferrets that received 2 doses of VN04 ca virus or the H5 HA DNA prime-VN04 ca virus boost regimen had serum Nt and HAI Ab responses against antigenically distinct H5N1 viruses